Are you Dr. Oldham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 85 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1701 Thomson Dr
Suite 200
Lynchburg, VA 24501Phone+1 434-200-5925Fax+1 434-200-6254
Summary
- Dr. Dwight Oldham, MD is an oncologist in Lynchburg, Virginia. He is currently licensed to practice medicine in Virginia. He is affiliated with Centra Lynchburg General Hospital.
Education & Training
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1976 - 1981
- Virginia Commonwealth University School of MedicineClass of 1976
Certifications & Licensure
- VA State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsUsing the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-06-01 - 92 citationsProfiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.Kai Wang, Jeffery S. Russell, Jessica D. McDermott, Julia A. Elvin, Depinder Khaira
Clinical Cancer Research. 2016-12-15 - 32 citationsAssociation of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gen...Michaela Tsai, Shelly S. Lo, William Audeh, Rubina Qamar, Raye Budway
JAMA Oncology. 2018-01-11